Fighting Covid-19: Best Available Treatment Study (Prof. Anthony Luder)

Prof. Anthony Luder, Azrieli Faculty Special Projects Advisor and Ziv Medical Center in Safed Director of Pediatrics, writes:

Paeditaric Inflammatory Multisystem Syndrome temporally associated with SARS-Cov-2 (PIMS-TC, known in the US as MIS-C) and coined "Cowasaki syndrome" by myself (because of its similarity with Kawasaki), was first diagnosed in Israel in Ziv at the end of April 2020 and since then has become a global, novel Corona associated systemic inflammatory syndrome seen almost exclusively in children, adolescents and young adults. I know of eight cases in Israel (including ours) of whom one has died. I have become the Israeli coordinator for an international research effort focused around Cowasaki and led by Professor Mike Levin at Imperial College London, called "BATS"  (Best Available Treatment Study). In addition, the Israel Paediatric association has appointed me to head up a special committee to write Israeli guidelines for this syndrome. For more information about "BATS," and/or to participate in the study, click here.